0001237899-14-000001.txt : 20140103 0001237899-14-000001.hdr.sgml : 20140103 20140103161017 ACCESSION NUMBER: 0001237899-14-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140103 DATE AS OF CHANGE: 20140103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powchik Peter CENTRAL INDEX KEY: 0001377247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 14505823 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-12-31 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001377247 Powchik Peter 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Clinical Development & Reg Common Stock 2013-12-31 4 M 0 48000.0 30.63 A 73447 D Common Stock 2013-12-31 4 F 0 5325.0 276.09 D 68122 D Common Stock 2013-12-31 4 F 0 22007.0 276.09 D 46115 D Common Stock 2014-01-02 4 S 0 3000.0 272.88 D 43115 D Common Stock 2014-01-02 4 S 0 5602.0 273.77 D 37513 D Common Stock 2014-01-02 4 S 0 3777.0 274.69 D 33736 D Common Stock 2014-01-02 4 S 0 6893.0 276.04 D 26843 D Common Stock 2014-01-02 4 S 0 1296.0 276.75 D 25547 D Common Stock 2014-01-02 4 S 0 100.0 277.5 D 25447 D Common Stock 1589 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 30.63 2013-12-31 4 M 0 48000.0 0.0 D 2020-12-14 Common Stock 48000 4736 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 3,000 shares of Company stock on January 2, 2014 at prices ranging from $272.20 to $273.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price. Represents volume-weighted average price of sales of 5,602 shares of Company stock on January 2, 2014 at prices ranging from $273.33 to $274.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price. Represents volume-weighted average price of sales of 3,777 shares of Company stock on January 2, 2014 at prices ranging from $274.35 to $275.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price. Represents volume-weighted average price of sales of 6,893 shares of Company stock on January 2, 2014 at prices ranging from $275.46 to $276.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price. Represents volume-weighted average price of sales of 1,296 shares of Company stock on January 2, 2014 at prices ranging from $276.48 to $277.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2014 at each separate price. The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013. /s/**Peter Powchik 2014-01-03